Key revisions and updates in the 2025 edition of the Chinese Pharmacopoeia, Volume I

Zonghua Song

Acupuncture and Herbal Medicine ›› 2026, Vol. 6 ›› Issue (1) : 1 -5.

PDF (372KB)
Acupuncture and Herbal Medicine ›› 2026, Vol. 6 ›› Issue (1) :1 -5. DOI: 10.1097/HM9.0000000000000187
Perspectives
research-article
Key revisions and updates in the 2025 edition of the Chinese Pharmacopoeia, Volume I
Author information +
History +
PDF (372KB)

Abstract

The 2025 edition of the Chinese Pharmacopoeia has been officially promulgated by the National Medical Products Administration (NMPA) and the National Health Commission (NHC). As the core of the traditional Chinese medicine (TCM) standards system, Volume I of the Chinese Pharmacopoeia further refines the standards for crude drugs and decoction pieces, strengthens the TCM safety risk prevention and control system, and actively advances the improvement of the TCM standards system. This edition will play a significant role in ensuring the quality of TCM products, safeguarding public health, and fostering high-quality development of the TCM industry.

Cite this article

Download citation ▾
Zonghua Song. Key revisions and updates in the 2025 edition of the Chinese Pharmacopoeia, Volume I. Acupuncture and Herbal Medicine, 2026, 6 (1) : 1-5 DOI:10.1097/HM9.0000000000000187

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Zhao YX, Wang Q, Gu J. Interpretation and reflection of special regulations on the management of traditional Chinese medicine standards. Chin Pharm J 2025; 60(2): 109-113.

[2]

Tu PF, Huang LQ, Chen WS, et al. Working ideas on amendment of quality standards of Chinese crude drugs and decoction pieces in Chinese pharmacopoeia (2020 edition). Mod Chin Med 2018; 20(12): 1459.

[3]

Cao H, Zhao WL, Hao JD, et al. Research on the Latin names of medicinal materials origins in Chinese pharmacopoeia (2020 edition). Chin Herb Med 2022; 45(4): 989-994.

[4]

Li ZG, Zhang HW, Wang HB, et al. Updates and amendments of standards for Chinese medicinal materials and decoction pieces characteristics in Chinese pharmacopoeia. Drug Stand China 2024; 25(1): 41-47.

[5]

Miao S, Mao XH, Zhou H. Current status of and suggestions for control of pesticide residues in traditional Chinese medicine. China Food Drug Adm 2022; 3: 96-103.

[6]

Li LM, Cao S, Ji S. Thoughts and suggestions on the control of heavy metals and harmful elements in traditional Chinese medicine. China Food Drug Adm Mag 2022; 3: 104-109.

[7]

Zhou H, Wang SM, Ji S. Current status and control strategy of mycotoxin contamination in traditional Chinese medicine. China Food Drug Adm 2022; 3: 110-118.

[8]

Xu XY, Wei SF, Zhang QM, et al. Additions and revisions of general chapters of physical and chemical analysis in the Chinese pharmacopoeia 2025 edition volume IV. Drug Stand China 2025; 26(1): 45-50.

PDF (372KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/